Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
- Oudaert, I. (Speaker)
- Menu, E. (Speaker)
Activity: Talk or presentation › Talk or presentation at a conference
Activity: Talk or presentation › Talk or presentation at a conference